Melanoma patients whose tumors test positive for mutations in the NRAS gene were more likely to benefit from new immunotherapy drugs, according to a new study led by Vanderbilt-Ingram Cancer Center (VICC) investigators.

Vanderbilt and the Waters Centers of Innovation Program are sponsoring a free symposium titled "Integrated 'Omics in Translational Medicine" on March 23. It is open to all scientists interested in the subject.

Vanderbilt University School of Medicine and Vanderbilt University School of Nursing have again been ranked among the nation’s elite “Best Graduate Schools” by U.S. News and World Report magazine.

Vanderbilt University researchers have achieved the first “image fusion” of mass spectrometry and microscopy — a technical tour de force that could, among other things, dramatically improve the diagnosis and treatment of cancer.

Vanderbilt University School of Nursing (VUSN) has been awarded a four-year, $2.4 million grant from the National Institutes of Health/National Institute of Dental and Craniofacial Research to establish a valid, clinically useful measurement battery for head and neck lymphedema and fibrosis (LEF).

Two Vanderbilt-Ingram Cancer Center (VICC) leaders have been named to a panel of the Institute of Medicine (IOM) to help shape national policies on the use of biomarkers for targeted cancer therapies.

To get a sense of how big a change it will be when a new medical coding and reporting system goes into effect later this year, consider this: The current system contains more than 14,000 codes for unique medical diagnoses. The new one has more than 68,000.